Viewing Study NCT04861467


Ignite Creation Date: 2025-12-25 @ 12:32 AM
Ignite Modification Date: 2025-12-29 @ 10:44 AM
Study NCT ID: NCT04861467
Status: NOT_YET_RECRUITING
Last Update Posted: 2021-04-27
First Post: 2021-04-22
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Camrelizumab as a Maintenance Therapy After Chemoradiation in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma
Sponsor: Chinese Academy of Medical Sciences
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module